Ladiratuzumab vedotin
Product Specifications
Specifications
4.16
Synonyms
SGN-LIV1A, Anti-LIV-1 ADC
SKU
C00998-1mg
Target
Antibody-Drug Conjugate
Applications
Others
Additionnal Information
Ladiratuzumab vedotin (SGN-LIV1A, Anti-LIV-1 ADC) is an antibody-drug conjugate (ADC) composed of humanized anti-LIV-1 antibody, conjugated to Monomethyl auristatin E (MMAE), via a proteolytically cleavable type linker. Ladiratuzumab vedotin has the potential for use in multiple carcinomas.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
